Search results
Showing 8151 to 8200 of 8900 results
This guidance has been updated and replaced by NICE guideline CG82.
Chronic obstructive pulmonary disease in over 16s: diagnosis and management (CG101)
This guideline has been updated and replaced by NICE guideline NG115.
This guideline has been updated and replaced by NICE guideline NG240.
This guideline has been updated and replaced by NICE guideline 42.
This guidance has been updated and replaced by NICE guideline NG231.
This guidance has been updated and replaced by NICE guideline NG133
This guideline has been updated and replaced by NICE guideline NG106.
All NICE products on peritoneal cancer. Includes any guidance.
All NICE products on penile and testicular cancer. Includes any guidance and quality standards.
All NICE products on liver cancers. Includes any guidance.
All NICE products on endometrial cancers. Includes any guidance.
All NICE products on colorectal cancer. Includes any guidance, advice and quality standards.
All NICE products on head and neck cancers. Includes any guidance and quality standards.
All NICE products on lymphoedema. Includes any advice.
All NICE products on sarcoma. Includes any guidance, advice and quality standards.
All NICE products on blood and bone marrow cancers. Includes any guidance, advice and quality standards.
All NICE products on biliary tract cancers. Includes any guidance and advice.
All NICE products on heart rhythm conditions. Includes any guidance, advice and quality standards.
All NICE products on peripheral circulatory conditions. Includes any guidance, advice and quality standards.
All NICE products on older people. Includes any guidance, advice and quality standards.
All NICE products on people with learning disabilities. Includes any guidance and quality standards.
All NICE products on people with physical disabilities. Includes any guidance.
All NICE products on genomic biomarker-based cancer treatments. Includes any guidance.
October 2018: This process guide has been updated. The updated version can be found in the tools and resources for developing NICE guidelines: the manual.
Process manual for the endorsement of guidance and quality standard support resources (PMG29)
The endorsement programme is now closed and no new applications are being accepted. Information about existing endorsed resources, are available on the endorsement webpage. Please email endorsement@nice.org.uk if you have any queries.
Medicines optimisation: key therapeutic topics – Integrated process statement (PMG13)
February 2022: we have withdrawn our medicines optimisation: key therapeutic topics. We have taken this decision after reviewing the wide range of services we currently provide, so we can focus on delivering the priorities outlined in our 5-year strategy. If you have any queries, please contact nice@nice.org.uk.
Process guide for adoption support resources for health technologies (PMG23)
This process and methods guide has been withdrawn.
Medical technologies evaluation programme methods guide (PMG33)
This medical technologies evaluation programme methods guide has been replaced by the NICE HealthTech programme manual.
This guide has been updated and replaced by practical steps to improving the quality of care and services using NICE guidance.
This interim methods and process guide for the proportionate approach to technology appraisals has been incorporated into NICE health technology evaluations: the manual.
Medical technologies evaluation programme process guide (PMG34)
This medical technologies evaluation programme process guide has been replaced by the NICE HealthTech programme manual.
February 2022: we have withdrawn our medicines optimisation: key therapeutic topics. We have taken this decision after reviewing the wide range of services we currently provide, so we can focus on delivering the priorities outlined in our 5-year strategy. If you have any queries, please contact nice@nice.org.uk.
This guideline has been updated and replaced by NICE guideline on depression in adults: treatment and management (NG222).
Venous thromboembolism: reducing the risk for patients in hospital (CG92)
This guidance has been updated and replaced by NICE guideline NG89.
This guideline has been updated and replaced by NICE guideline NG185.
This guidance has been updated and replaced by NICE guideline CG56.
Urinary incontinence: the management of urinary incontinence in women (CG40)
This guidance has been updated and replaced by NICE guideline CG171.
This guidance has been updated and replaced by NICE guideline CG164.
Dementia: supporting people with dementia and their carers in health and social care (CG42)
This guidance has been updated and replaced by NICE guideline NG97.
This guideline has been updated and replaced by NICE guideline NG246.
This guidance has been updated and replaced by NICE guideline NG88.
Antenatal and postnatal mental health: Clinical management and service guidance (CG45)
This guidance has been updated and replaced by NICE guideline CG192.
This guidance has been updated and replaced by NICE guideline CG92.
This guidance has been updated and replaced by NICE guideline CG160.
This guidance has been updated and replaced by NICE guideline CG172.
This guideline has been updated and replaced by NICE guideline CG108.
Obesity in adults: prevention and lifestyle weight management programmes (QS111)
This quality standard has been updated and replaced by NICE quality standard 212.
This quality standard has been updated and replaced by NICE quality standard 184.
This guideline has been updated and replaced by NICE guideline NG246.
This guideline has been updated and replaced by the NICE guideline on intrapartum care (NG235).